PCHi 2026: Ashland debuts Eternight in China to target longevity trend
10 Apr 2026 | Ashland
Frédéric Faugeroux of Ashland highlighted the global debut of Eternight, marking the company’s first time initiating a worldwide ingredient launch in China. He emphasised the importance of regional customization, noting that trends such as skin brightening remain highly relevant in China and require targeted ingredient development. Backed by a Shanghai-based clinical lab established in 2006, Ashland continues to tailor innovations to local market needs, positioning longevity as a key driver in the evolution of high-performance, consumer-focused beauty solutions.
